Aureomycin®
For: Beef Cattle, Dairy Cattle - Available in: United States
As a medicated feed additive, Aureomycin® (chlortetracycline) provides treatment options for beef cattle and non-lactating dairy cattle under 20 months of age against a range of respiratory and enteric diseases through feed rations.
Indications
Approved for:
- Treatment and control of bacterial pneumonia caused by Pasteurella multocida in beef cattle and growing heifers.
- Treatment of bacterial enteritis and pneumonia caused by Escherichia coli (E. coli) in calves, beef and non-lactating dairy cattle
- Control of active infection of anaplasmosis caused by Anaplasma marginale in beef and non-lactating dairy cattle
- Reduction of liver condemnations due to liver abscesses in growing cattle
Key Features
- Broad spectrum, effective against a range of respiratory and enteric diseases
- Effectively controls Pasteurella multocida species
- Treatment of bacterial enteritis caused by E. coli
- Control of active infection of anaplasmosis caused by Anaplasma marginale
- Approved for use in combination with Bovatec® Type A Medicated Article, Deccox® Type A Medicated Article or Cattlyst® Type A Medicated Article
- Approved for use in top-dress supplements
- Versatile product with applications in all phases of beef production, excluding veal
- Convenient treatment option when individual animal handling is not practical
- Reduces incidence of liver abscesses
- Zero-day withdrawal
Available in both granular and meal form
Approved Aureomycin cross clearances:
- Bovatec®
- Deccox®
- Cattlyst®
- MGA®
- MGA and Bovatec
Do not use Aureomycin in calves to be processed for veal.
Caution: Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.
- Drug Bank Online. Pharmacology. Chlortetracyclines. https://go.drugbank.com/drugs/DB09093.Opens in a new window Accessed September 4, 2024.